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Recent investigations have revealed a  variety of types of heterogeneity for 
human 7-globulin  (1). In addition to the three immunoglobulin classes (7S 7, 
19S 7,/32A),  it may be further divided by the presence of group I  and group ]I 
molecules  (27 3)  and  by  the  presence  or  absence  of  various  genetic  factors 
controlled by alleles at two genetic loci (the Gm and Inv loci) (4). 
Studies  of isolated human antibodies  against single antigens have revealed 
that they may be more homogeneous than the whole 7-globulin of their donor 
in their electrophoretic mobility (5,  6)  and in the electrophoretic mobility of 
their isolated  light  chains  (7).  Recent  studies  have also  shown  that  isolated 
antibodies may vary in the ratio of group I and group II molecules (8) and may 
have individual antigenic specificity (6). Thus, isolated human antibodies ap- 
proach  the  homogeneity of myeloma proteins in  many ways. In view of the 
selective distribution of genetic (Gin and Inv) factors in myeloma proteins (9), 
the present study was undertaken to explore the distribution of genetic factors 
in isolated human antibodies. The findings indicate that many such antibodies 
are qualitatively or quantitatively limited in  their content of genetic factors, 
compared with the whole T-globulin of the donor. 
Materials and Methods 
Antisera.--Human antisera were obtained from fourteen individuals previously immunized 
against dextran  (10, 11)  and from two individuals immunized with porcine blood group A 
substance (To. and Wh.). Antisera were also obtained from three patients with systemic lupus 
erythematosus, one for antinuclear antibody (Th.) and two (Lu. and An.) for antibody against 
teichoic acid isolated from Staphylococcus aureus (12-14). Antibody against teichoic acid was 
also obtained from one patient with rheumatoid arthritis  (Ft.), from two normal individuals 
who had been immunized with teichoic acid (Bo. and  Da.), and from several of those im- 
munized against dextran. Serum was obtained from one individual (subject 1) who had been 
immunized with porcine blood group A substance, alum-precipitated tetanus toxoid, levan, 
and dextran (11); this serum also contained antibody against teichoic acid. 
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Isolation and Preparation of Antibody.--Appropriate  sera were cleared by ultracentrifuga- 
tion and absorbed for  1 to  7 days with dextran, levan, teichoic acid, or alum-precipitated 
tetanus toxoid in ratios at or near the points of maximal precipitation. When more than one 
antibody was harvested from the same serum, sequential absorptions were used. The resulting 
precipitates were separated by centrlfugation and washed six times in cold phosphate buffer 
at pH 7.4 and ionic strength 0.15.  Antinuclear antibody from patient Th. was absorbed onto 
calf thymus nuclei (15) and separated from the serum by centrlfugation and washing. Teichoic 
acid antibody in serum from donors 1,  173, 98, 205,  and Fo. was precipitated with teichoic 
acid supplied by Dr. J. L. Strominger, and that in the remaining sera was precipitated with 
teichoic acid supplied by  Dr.  S.  Morse. 
Washed antigen-antibody precipitates of levan, blood group A substance, and teichoic acid 
were dissolved by addition of excess of the respective antigens. Dextran-immune precipitates 
were treated with dextranase by the method previously described  (16).  Teichoic acid pre- 
cipitates from some patients were digested with papain at pH 7.4 after the method of Porter 
(17), as was the tetanus toxoid immune precipitate from 1. As a control for the effect of papain 
treatment of these antibodies on genetic typing, four dextran antibody solutions (176,  49, 
Ca.,  20), anti-A substance Wh., and the teichoic acid immune precipitate from patient An. 
were digested with papain by this method. In each instance results of Gm genetic typing were 
identical with those found with the undigested material. Inv(a) typing was not performed on 
papain-digested antibodies, as it was not clear what effect this treatment had on dissolving 
the antibody S fragments known to contain both the Inv determinant and the antibody com- 
bining site (18,  19). Antiblood group A immune precipitate from subject 1 was dissolved in 
excess porcine blood group A substance, while antibody from the anti-A immune precipitate 
of To. and Wh. was eluted with pit 3.8 acetate buffer as previously described (6). Antibody 
from Th., absorbed on calf thymus nuclei, was eluted by treatment with deoxyribonuclease as 
described by Holman and Deicher (20). 
All antibody solutions were dialysed to a pH of 7 against a  phosphate buffer of that pH 
and 0.1 ionic strength prior to genetic typing. Protein concentrations were determined by the 
Folin-Ciocalteu method (21) and concentrated where necessary to at least 0.5 mg/ml by mem- 
brane filtration at 4°C under pressure. Normal individual T-globulin of known phenotype was 
isolated by zone electrophoresis on starch (22) for comparison titrations. 
Analysis  of Immunoglobulin Composition.--Quantities of 26 of the 33 antibodies studied 
were adequate to allow semiquantitative estimation of relative proportions of 7S 5'-, 19S 5'-, 
and ~-immunoglobulin classes. This group included 10 of the 13 antibodies found deficient 
in both Gm factors, and included representatives of all specificities studied. Serial doubling 
dilutions of the antibody solution were reacted with rabbit antisera specific  for 19S or/3~- 
globulins in a  double diffusion in agar system as previously described (8). Comparison titra- 
tions with these antisera were made against immunoglobulin solutions of known concentration 
under the same conditions. The presence of 7S immunoglobulin or its fragments was verified 
by agar diffusion against a rabbit antiserum specific for the fast fragment of papain-digested 
human 7S 5"-globulin. 
Gm and Inv Typing.--Gm(a) and Gin(b) typing was performed by a  slide technique, and 
Inv  (a) by a tube technique, in the inhibition of agglutination procedure as previously reported 
from this laboratory (9). All preparations were tested at a  protein concentration of at least 
0.5 mg/ml. Appropriate controls for non-spedfic agglutination of the coated cells by the anti- 
body solutions were run with each determination. Similarly, control tests showed that none 
of the antigens used in this study inhibited any of the test systems at appropriate concentra- 
tions. Quantitation of inhibiting capacity was performed in simultaneous tests on serial dou- 
bting dilutions of those antibodies which were found to inhibit the test system in the undiluted 
state. The degree of agglutination was visually graded unmagnified in the Inv(a) tube test, 
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*/-globulin  of each donor was performed  on whole serum diluted  1:10 and 1: 20 with normal 
saline. 
Fresh group O, Rh0 red blood cells  from one of two donors were used throughout these ex- 
periments. The agglutinators were all from non-rheumatoid donors and were specific only 
for the factor tested. Specificity  of each agglutinator anti-D system was established by typing 
20 normal sera of known phenotype. Coating of red cells  with the incomplete  anti-D sera was 
performed in a standard manner and gave reproducible Coombs titers. 
The specific reagent systems and the dilutions at which they were used in this study are 
listed below. 
Factor  Agglutinator  Anti-D 
Gin(a)  Smejsa 1/30  2368 1/5 
Gin(b)  A. Berg 1/20  Black 1/5 
Inv(a)  LeClerc 1/20  Roehm 1/5 
RESULTS 
Results of inhibition titrations on the isolated antibodies are presented in 
Tables I, II, and III for the Gm(a),  Gin(b), and Inv(a) factors respectively. 
Wh.  anti-A inhibited  the  Gin(a)  system through a  protein concentration of 
0.03 rng/ml and both Wh. anti-A and Th. anti_nuclei inhibited the Gm(b) sys- 
tem through 0.06 mg/ml.  These antibodies had inhibiting capacities in these 
systems one tube higher than that of isolated homozygous whole "/-globulin. 
Antidextrans from 54, 220, and 1 and antilevan from 1, isolated from Gm(a-t-) 
donors, failed to inhibit the Gm(a) system at the highest concentration. Sim- 
ilarly, a  number of antibodies isolated from Gm(bq-) donors failed to inhibit 
the  Gm(b)  system at  any concentration tested.  Inhibition by other isolated 
antibodies varied  between  these  extremes. Bo.,  1,  and  Fr.  antiteichoic acid 
antibodies did not  totally suppress  the  Gin(a)  and/or  Gm(b)  system at the 
highest protein concentration at which they were studied, but they gave pat- 
terns of partial inhibition which were different from any pattern seen in titration 
of antibodies isolated from Gm(a-)  or Gin(b-)  individuals. In no instance 
did  an  antibody isolated from a  donor whose "y-globulin  lacked  the genetic 
factor being titered show even partial inhibition of the test system. 
Fo. antidextran inhibited  the Inv(a)  system at a  protein concentration of 
0.12 mg/ml which is one tube lower than that of the Inv(a+) whole "y-globulin. 
In this system, as in the Gin(a) and Gm(b) systems, a gradation in inhibiting 
capacity was seen, with antibodies isolated from Inv(a-]-) donors Ft., 54, and 
220 failing to inhibit the Inv(a) system at any concentration tested. It is worth 
noting that the antiteichoic acid antibodies from Ft. and Fa. were isolated at 
the same time and under identical conditions. Fa.  antiteichoic acid inhibited 
the Inv(a) test system to 0.5 rng/ml while Ft. antiteichoic acid gave no inhibi- 
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TABLE  I 
Inhibition of Gm (a) Typing System by Isolated A n~ibodies 
Donor 
Wi. 
Wh. 
An. 
Ma. 
Th. 
49 
186 
l:a. 
1 
Ca. 
1 
30 
Lu. 
Bo. 
1 
54 
220 
1 
1 
A1. 
20 
173 
Da. 
216 
]70. 
Fo. 
Fr. 
98 
98 
205 
205 
To. 
176 
176 
201 
Donor 3  ~- 
p~lObulin 
enotype 
Gin(a+) 
Gm(a-) 
¢c 
An  tibody 
Whole T-globulin 
A substance 
Teichoic acid 
Dextran 
Nuclei 
Dextran 
Teichoic acid 
Tetanus toxoid 
Dextran 
A substance 
Dextran 
Teichoic acid 
Dextran 
Levan 
Whole "y-globulin 
Dextran 
Teichoic acid 
Dextran 
Teichoic acid 
Dextran 
Teichoic acid 
Dextran 
Teichoic acid 
A substance 
Dextran 
Teichoic acid 
Dextran 
Agglutination of test system at various con- 
centrations  of inhibitor  (antibody), mg/ml 
1.0  0,5  0.2,  ~ 
0  0  0 
--'  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
--  0  0 
--  0  0 
0  0  0 
0  0  1 
0  0  1 
0  0  1 
0  1  2 
1  2  3 
1  2  3 
--  3  3 
--  3~  3 
--  3  3 
3  3  ~  3 
3  3  ~  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  313 
3  3  3 
--  3  3 
3  3  3 
3  3  3 
3  3  3 
--  3  3 
0.12  0.06 
0  0 
0  0 
0  0 
0  1 
0  1 
1  2 
1  2 
1  2 
1  2 
2  3 
2  3 
2  3 
3  3 
3  3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
0.031 ~  ~-- 
0  1 
1  2 
2  3 
2  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3  3 
3  3  3 
3  3  3 
3!  3  3 
3  ~  3  3 
31  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3!  3  3 
31  3  3 
3!  3  3 
3333 
3  3 
3  3 
3  3 
3  3 
3  3 
* Not available for testing. 
The patterns of partial inhibition of the Gm test systems by antiteichoic acid 
antibodies from Bo., 1, and Ft. probably represent small concentrations of those 
Gm  factors  in  the  antibody  solutions.  This  is  supported  by  the  observation 
that  no  antibody  isolated  from  an  individual whose phenotype  was  negative JAMES  C.  ALLEN~ HENRY  G.  KUNKEL,  AND  ELVIN  A.  KABAT 
TABLE  II 
Inhibition of Gin(b) Typing System by Isolated Antibodies 
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Donor 
Donor T- 
~lobulin 
pllenotype 
Gm(b-[-) 
lc 
lc 
cc 
cl 
cl 
lc 
cc 
lc 
~¢ 
lc 
lc 
Gin(b--) 
Antibody 
Whole "/-globulin 
Nuclei 
A substance 
Teichoic acid 
Tetanus toxoid 
Dextran 
Teichoic acid 
Dextran 
A substance 
Dextran 
c¢ 
Teichoic acid 
Dextran 
Teichoic acid 
¢c  ¢c 
Dextran 
A substance 
Levan 
Teichoic acid 
Dextran 
Teichoie acid 
Dextran 
Teichoic acid 
¢c  c¢ 
Dextran 
Whole 3c-globulin 
Dextran 
c~ 
~c 
Agglutination  of test system at various  con- 
centrations  of  inhibitor  (antibody),  mg/ml 
1.0  0.5  0.25  0.12  0.06  0.03  0.015  0 
2 
for a Gm factor showed any inhibition of the test system for that factor. These 
test systems can detect the Gm or Inv(a) factors if they represent no less than 
about 5 per cent of the protein concentration at 1 mg/ml or about 10 per cent 
at 0.5 mg/ml. It appears probable that with a more sensitive technique, certain 
of the antibodies which gave no detectable inhibition would give evidence of 458  STUDIES  ON  HUMAN  ANTIBODIES.  II 
small amounts of the genetic factors, when obtained from phenotypically posi- 
tive donors. 
Table IV allows comparison between the Gin(a), Gm(b), and Inv(a) pheno- 
type of each donor and the ability of antibodies isolated from them to inhibit 
the  various test  systems.  Inhibition capacity was  graded  as  (-)  for  no  de- 
TABLE III 
Inhibition  of Inv(a)  Typing  System  by  Isolated Antibodies 
Donor 
Al. 
Fo. 
Fa. 
98 
Th. 
Da. 
Fr. 
54 
220 
Wi 
An. 
20 
Bo. 
49 
186 
1 
205 
205 
Lu. 
Ma. 
3O 
176 
201 
Donor "y- 
p~lObulin 
enotype 
Inv(a+) 
lc 
Inv(a--) 
~c 
lc 
Antibody 
Whole "),-globulin 
Dextran 
Teichoic acid 
Dextran 
Nuclei 
Teichoic acid 
Dextran 
Whole "y-globulin 
Teichoic acid 
Dextran 
Teichoic acid 
Dextran 
Teichoic acid 
Dextran 
Agglutination of test system at various con- 
centrations of inhibitor  (antibody), mg/ml 
1.0  O.S 
0  0 
0  0 
--  0 
0  0 
0  -- 
0  1 
3  3 
--  3 
--  3 
3  3 
3  3 
3  3 
3  3 
3  3 
--  3 
--  3 
3  3 
--  3 
3  3 
3  3 
3  3 
3  3 
3  3 
0.25  12  0.06 
0  0  0 
0  0  1 
1  2  3 
1  2  3 
2  3 
3  3 
3  34  3 
3  31  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3  3 
3  3[  3 
3  3]  3 
3  313 
3  3  3 
3  3  3 
0.03  0.015 
1  2 
2  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3  3 
3i3 
0 
3 
tectable inhibition through 5+  for inhibition at ~ higher dilution than isolated 
5,-globulin of that phenotype.  It is apparent  that  the presence of detectable 
quantities of the various genetic factors in isolated antibodies was independent 
of  the  antibody specificity. Among  the  antiteichoic  acid antibodies,  An.  in- 
hibited Gin(a) but not Gin(b), Da. inhibited Gm(b) but not Gin(a) and  1 and 
205 inhibited in neither system. In titrations of the Inv(a) factor in antibodies 
isolated from  Inv(a+)  donors,  Fa. antiteichoic acid and  Fo. antidextran in- 
hibited the test system, while Fr. antiteichoic acid and 54 antidextran did not. 
Among anfidextran antibodies, Ca. and Ma. inhibited Gin(a) but not Gin(b), JAMES  C.  ALLEN,  HENRY  G.  KUNKEL,  AND  ELVIN  A.  KABAT  459 
20  inhibited  Gin(b)  but  not  Gin(a),  and  1,  220,  and  54  inhibited  in  neither 
system. 
It should be noted that antidextran  antibodies from 1, 220,  and 54 failed to 
inhibit any of the genetic typing systems in this study, though serum from two 
TABLE IV 
Phenotypes of Donor T-Globulin and Isolated Antibodies 
Donor  •  Antibody 
1  Dextran* 
Levan* 
Teichoic acid~ 
A substance* 
Tetanus toxoid~ 
Wh.  A substance* 
Ca.  Dextran* 
An.  Teichoic acid* 
Bo.  "  " 
Lu.  "  " 
220  Dextran* 
Th.  Nucleill 
54  Dextran* 
Fa.  Teichoic acid* 
30  Dextran* 
Ms.  " 
186  " 
To.  A substance* 
20  Dextran* 
216  " 
176  " 
Teichoic acid 
205  Dextran* 
Teichoic acid* 
201  Dextran* 
Fo.  ~ 
Teichoie acid ~: 
98  Dextran* 
Teichoic acids 
173  "  "  :[: 
Fr.  "  "  * 
Da.  "  "  * 
Serum Gm  Antibody Gm  Serum  Antibody 
phenotype  phenotype  Iuv (a)  Inv(a)  phenotype phenotype 
a~d.b~  ,.  ~.. 
cc 
cc 
cc 
~c 
c~ 
cc 
cc 
cc 
cc 
cc 
a4+b_ 
cc 
a-_b4+ 
c¢ 
lC 
4G 
d~ 
a_b_  a_ 
~c 
cc 
ax+b_ 
a2+b4+ 
a~b~  " 
al+b-  " 
a2+b~-  " 
a4+b_  " 
al+bl+  " 
al+b-  " 
a_b_  a4+ 
a3+b~  " 
a_b_  " 
a~b~-  " 
al+b_  a_ 
a~_b_  " 
a~b_ 
a._b~_  " 
a_b~- 
a_.b~  " 
cg  ~C 
a__b_ 
cc  ~ 
c~ 
¢~  ¢c 
a_b~  a~ 
a-b1+ 
lc  cc 
a_b_ 
cc  ~¢ 
a-bl+  " 
a--b4+ 
cc 
~c 
c~ 
CC 
a>l+ 
a_ 
al+ 
a-. 
c~ 
c~ 
cc 
cc 
aa4- 
al+ 
a_ 
al+ 
Content of 
~2A  19S  T 
per cent  per ce~t 
0  0 
0  0 
Trace§  5-15 
0  10-20 
0  0 
5-15  0 
0  5-15 
5-15  5-15 
Trace  Trace 
5-15  0 
5--15  0 
0  15-25 
0  Trace 
0  0 
0  0 
Trace  0 
0  0 
Trace  0 
"  0 
0  0 
0  0 
0  0 
Trace  0 
"  0 
"  0 
5-15  Trace 
* Dissolved in  excess  antigen. 
Papain-digested. 
§  Less  than  5  per  cent. 
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of these individuals contained all three genetic factors, and serum from the 
other donor had two. These antibodies were isolated by procedures identical 
with those used  to prepare  antidextran antibodies found to contain Gin or 
Inv(a) factors, and all were predominantly 7S ~t-globulin by immunoglobulin 
analysis. 
Results of semiquantitative estimation of 19S and/3~ content of 26 of the 33 
antibodies used in this study are also shown in Table IV.  Strong precipitin 
bands were seen in each instance between the isolated antibody and an anti- 
serum specific  for the fast fragment of 7S  "~,-globulin. In only one instance 
(antidextran from 49) did the approximate content of 19S and/3~A v-globulin 
exceed 20 per cent of the total antibody protein. The remaining antibodies were 
estimated to contain less than 20 per cent 19S or/32A v-globulin, and a number 
had no detectable amounts of these immunoglobulins. Several isolated anti- 
bodies were excluded from this study because they contained more than 30 
per cent 19S and/3~A "y-globulin. 
DISCUSSION 
Studies of isolated myeloma proteins and Waldenstr6m macroglobulins have 
shown these proteins to be homogeneous in their content of the genetic ~/-globu- 
lin factors and of the group I  and group II determinants. These findings sug- 
gested that a clone of v-globulin-producing cells releases molecules which have 
only one of two possible allelic genetic factors, and either group I or group II de- 
terminants (9, 23). In addition, a significant percentage of clones are thought 
to produce ~,-globulin carrying genetic determinants for which there are as yet 
no identifying test systems (Gin and Inv negative). Assigning the frequency 
of various genetic factors among monoclonal v-globulins would allow a calcula- 
tion of percentage distribution of the various clones of v-globulin-producing 
cells, based on their genetic type. Currently available data, however, are not 
adequate  to  allow an  accurate appraisal  of this distribution for all factors. 
There is reasonable evidence that over 80 per cent of clones in a Gin(b) homo- 
zygous individual produce "Gm negative" 7S v-globulin (23, 24).  In the case 
of Gm(a) homozygous individuals the information is more limited, but it is 
probable that up to 40 per cent of the ~'-globulin-producing clones in such an 
individual produce Gin-negative v-globulin (24). 
The number of isolated antibodies from Gm-positive donors which failed to 
inhibit either the Gm or the Inv(a) system would undoubtedly be reduced by 
more sensitive techniques. Within the limits of the methods used, however, a 
higher per cent of the antibodies from Gin(a-I-) donors clearly inhibited the 
Gin(a) system than was found for inhibition of the Gin(b) system by antibodies 
from Gm(b~)  individuals. This is in general agreement with the prediction 
from the myeloma data that a  Gm-positive individual has a greater number of 
Gin(a) than Gin(b) "r-globulin producing clones (25, 9). JAMES  C.  ALLEN,  HENRY  G.  KUNKEL,  AND  ELVIN  A.  KABAT  461 
Unfortunately, the Inv(b) testing system now available has proven too vari- 
able  to allow conclusions on the distribution of this factor in isolated  anti- 
bodies. To offset this deficiency antibodies were obtained from as many Inv(a+) 
individuals  as possible. This factor also showed selective distribution similar 
to that found with the Gm(a) and Gin(b) factors.  Current information on the 
distribution of the Iuv(b) factor among myeloma  proteins and in whole ~,-globu- 
lin of the normal population gives no reason to suspect that the Inv(b) factor 
would be distributed in a different fashion than the Inv(a) in these antibodies, 
except perhaps  in frequency. 
Consideration should be given to the possibility that some of the deficiencies 
in the genetic factors in the isolated antibodies might be due to alterations in 
the  antibody during the course  of preparation,  particularly in view  of the 
variety of methods utilized.  However,  this  explanation  appears  remote,  at 
least for most of the antibodies studied, because for each of the methods utilized 
positive results were obtained with certain antibodies. In addition, and perhaps 
of more importance, is that some of the antibodies from Gm(a+b+) sera served 
as their own controls,  giving differential  inhibition in the Gm(a) and Gin(b) 
systems.  For  example,  An.  antiteichoic acid  strongly inhibited  the  Gin(a) 
system but failed to inhibit the Gin(b) system. Antitetanus toxoid from donor 1 
on the other hand, inhibited the Gm(b)  system to a significantly greater de- 
gree  than the  Gm(a)  system. 
It is interesting to note that 5 antibodies  isolated  from a  single donor,  1, 
had  a  variety of inhibitory patterns.  Three of the antibodies  (antidextran, 
antilevan, and antiteichoic acid) failed to inhibit either Gm system, 1 (anti-A 
substance) inhibited the Gm(a) but not the Gm(b) system, and the 5th antibody 
(antitetanus toxoid) inhibited both systems,  but to a significantly greater de- 
gree in the Gin(b)  titration. 
Since the ~, and 19S classes of immunoglobulins lack Gm determinants (1), 
it was important to carry out analyses for these immunoglobulins on the various 
isolated antibodies. Antigenic analysis by semiquantitative techniques indicated 
definite ~fl~A  and 19S material in many instances. The highest concentration was 
in antidextran from 49, in which as much as 30 per cent of the antibody protein 
was 19S and ~2A ~-globulin. This antibody which showed partial inhibition in 
both Gm systems might well have been a stronger inhibitor as a pure 7S frac- 
tion. The remainder showed less than 20 per cent of these other immunoglobu- 
lins which was insufficient to affect the inhibition titers significantly. A number 
of the antibodies  which lacked detectable Gm determinants showed only the 
presence of 7S 3,-globulin (antilevan and antiteichoic acid from 1, antiteichoic 
acid from 176, and antidextrans from 201 and 205). 
Differences between  the distribution of genetic  factors in whole ~/-globulin 
and  in  isolated  antibodies  indicate a  relative homogeneity of the  antibody 
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group II determinants in isolated antibodies (8). Many antibodies in this study 
were those utilized in the preceding paper  in which the electrophoretic dis- 
tribution of isolated light chains from human antibodies was studied (7).  An 
effort was made to correlate the banding of L  chains with the complement of 
genetic factors found in the antibodies. Antidextran antibodies tended to show 
sharp banding of the L  chains, and these antibodies also showed deletions of 
Gm and Inv factors by genetic typing. Anti-A Wh.  showed marked hetero- 
geneity of L chains and also had a full complement of Gm genetic factors. In 
other instances this correlation was not evident. 
Previous studies on genetic factors present in incomplete anti-Rh antibodies 
have indicated that these antibodies may lack factors present in the donor's 
-r-globulin  (26, 27). There had been suggestive evidence from these studies of a 
high  percentage  of  Gm(b)  deficiency in  anti-Rh  antibodies  from  Gm(b-t-) 
individuals,  although  such  interpretations  were  possibly  compromised  by 
difficulties inherent in the test system. The present observations with other 
antibodies suggest that similar Gm(b) deficiencies  in Rh antibodies would be 
highly likely. 
Gell and Kelus reported the absence of one and possibly two allotypes of 
"r-globulin in an antihapten antibody isolated from a rabbit (28). Recent studies 
by Rieder and Oudin (29),  also in the rabbit, have demonstrated alterations 
in the normal ratios of various allotypic globulin factors in isolated antibodies 
against ovalbumin and DNP-bovine 3,-globulin.  They noted no complete de- 
letions of genetic factors present in the whole "r-globulin  of the donor animal. 
It has been established that those allotypes of rabbit "y-globulin which are con- 
trolled by the same genetic locus lie on different 3,-globulin molecules (30-32), 
which is in line with the human work showing that myeloma proteins contain 
only one allelic factor even in heterozygous individuals. 
The  present  studies indicate that  certain  isolated human  antibodies  give 
results for the distribution of genetic factors similar to those obtained in studies 
of isolated human myeloma proteins. The pattern of distribution with isolated 
antibodies could result from the  stimulation of only a  few of the potential 
"r-globulin-producing cell types, either because of the limited antigenic speci- 
ficity of some of the antigens, or because of the minimal doses used for im- 
munization. Antidextran antibodies which in many instances showed marked 
genetic deletions were directed against a  limited number of determinants (10, 
33), while many of the other antibodies probably were directed against a con- 
siderably larger  number  of different antigenic groupings,  for example  anti- 
tetanus toxoid. It seems possible that antibodies to a  single antigenic deter- 
minant produced in heterozygous individuals might, like the myeloma proteins, 
show only one or the other allelic factors but never both. On the other hand, 
the weak antigenic stimulus used to immunize many of these individuals may 
have influenced the number of cells  responding and hence resulted in a  de- JAMES C. ALLEN, REIqI%Y G. KUNKEL,  AND ELVIN A. KABAT  463 
ficiency of the Gin and Inv determinants. However, it should be mentioned 
that some of the antibodies showing deletions were present in high concentra- 
tions in the originaI serum. The exact roles of the heterogeneity of antigenic 
determinants and the strength and duration of antigenic stimulus in limiting the 
genetic heterogeneity of antibody protein remain to be evaluated. 
SUMMARy 
Human antibodies against dextran, teichoic acid, blood group A substance, 
levan, tetanus toxoid, and nuclei were isolated and analyzed for their content of 
Gin(a), Gm(b), and Inv(a) "y-globulin genetic factors. The majority of these 
antibodies contained all the genetic factors determined in the donor's whole 
-y-globulin, but in many antibodies at very different concentrations. In a few 
instances specific  factors could not be detected despite their presence in the 
individual's whole ~/-globulin. Different antibodies isolated from the serum of 
the same individual showed different relative concentrations of genetic factors. 
The distribution of genetic factors seen in certain isolated human antibodies 
appeared to approach the selective occurrence of these factors in myeloma pro- 
teins. 
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